Digital transformation in Women's Health
How smart breast reading solutions support in catching up on delayed cancer screenings
|
|
|
Fear of infection, overflowing intensive-care wards and labor-intensive measures to protect against infection: COVID-19 is pushing both healthcare systems and patients to their limits, and that's now also impacting cancer care. The huge burden on healthcare systems could result in delayed diagnoses and treatment. Add in missed cancer screenings, and the result could be dramatic, potentially costing many lives. Find out how we have made a digital transformation in Women's Health and how new smart digital innovations in breast care can help to close this healthcare gap.
|
|
The full spectrum of multimodal diagnostics powered by Next-Gen AI solutions1
|
Mammography reading is faced with an increasing volume of data from multiple sources, staff shortages, and more intricate reading due to the rise of tomosynthesis in national screening programs. As the digital transformation of healthcare continues, advanced, multimodal visualization solutions for breast health need to transform clinical operations: see how MAMMOVISTA B.smart2 can help to reach new levels of performance3 and accuracy4 while reducing the workload thanks to AI support1.
›
Read more
|
|
|
|
|
|
|
|
New innovation supports workflow optimization and high quality of care in breast imaging
|
How do you tackle the globally prognosed staff shortage also seen in breast imaging and make sure to continuously improve your services in breast imaging? To complement the digital solutions in Women's Health, teamplay Mammo Dashboard5,6 is designed to provide an intuitive overview of institution-specific KPIs and scan-related data to reveal optimization potentials and support a high quality of care in breast imaging.
›
Read more
|
|
|
|
|
1 This feature is an option and available with MAMMOVISTA B.smart. Transpara® Powered by FusionAI, ScreenPoint Medical.
2 MAMMOVISTA B.smart is under development and not commercially available. Its future availability cannot be ensured. Please contact your local Siemens Healthineers organization for further details.
3 Data on file.
4 FDA wide-angle DBT reader study with Transpara, approval number K193229.
5 teamplay products are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details. GUI und User Guides are only available in English, other languages will be supported soon. Please contact your local Siemens Healthineers organization for further details.
6 teamplay Mammo Dashboard supports selected Siemens Healthineers Mammography systems. Please contact your Siemens representative for more details.
|
|
|
|
